Stem cells are the primordial cells of human beings. These self-renewing, undifferentiated cells can mature into any of the 210 different cell types which make up the tissues and organs of the human body. In 1998, scientists learned how to harvest stem cells from human embryos. In theory, stem cells have the potential to supply fresh transplant material to replace the cells that are lost to many incurable illnesses including Alzheimer’s, Parkinson’s, cancer and diabetes. In fact, scientists have recently created insulin-producing pancreatic beta cells from embryonic stem cells, a big step towards curing diabetes. It is believed stem cells can also be used to repair spinal cord injuries and to cure or replace ailing hearts and livers. All told, these major advancements in regenerative medicine could improve the lives of more than 100 million Americans. Over time, technical advances enabled embryonic stem cells to be produced without using embryos. Transplanting genetic material from an adult cell into an egg whose own DNA had been removed, enabled scientists to clone adult cells into embryonic stem cells. Called pluripotent stem cells, these cells are easier to make, provide an unlimited supply of material, and are free of the ethical concerns regarding the destruction of human embryos. Pluripotent stem cells can grow into almost any tissue that is genetically identical to a patient. However, breakthroughs in stem cell research continue to occur at a regular pace. Researchers have recently discovered a way of changing adult cells back into their original embryonic state. Exposing adult cells to a simple acid bath in a low oxygen environment has been found to turn some cells in the body into stem cells that could be used for tissue repair and other treatments. Advocates say the rapid advancements in stem cell research prove revolutionary treatments for illness and injury are close at hand. They say the pace of these advancements depend on the amount of funding dedicated to regenerative medicine research.
S.136 – Ethical Stem Cell Research Tax Credit Act of 2013
H.R.1740 – Patients First Act of 2013
H.R.2164 – Human Cloning Prohibition Act of 2012
I oppose reforming current stem cell policy and wish to defeat S.136, H.R.1740, and H.R.2164
I support allowing a tax credit for 30% of qualified stem cell research expenses paid or incurred in a taxable year. Defines “qualified stem cell research expenses” as expenses for carrying out basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of or treatments for diseases and other adverse health conditions. Prohibits a tax credit for any research expenses that may involve: the creation of a human embryo for research purposes; the destruction of or discarding of, or risk of injury to, a human embryo, and wish to pass S.136
I support conducting and supporting basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not such pluripotent stem cells have an embryonic source), provided that such techniques will not involve: the creation of a human embryo for research purposes; the destruction or discarding of, or risk of injury to, a living human embryo, and wish to pass H.R.1740
I support prohibiting any public or private person or entity from: performing or attempting to perform human cloning; participating in an attempt to perform human cloning; or shipping, receiving, or importing the product of human cloning for any purpose; setting criminal and civil penalties for violations. Provides that nothing in this Act shall restrict areas of scientific research not specifically prohibited by this Act, including research in the use of nuclear transfer or other cloning techniques to produce molecules, DNA, cells other than human embryos, tissues, organs, plants, or animals other than humans and wish to pass H.R.2164